Synlico Recognized as BioPharma Honorable Mention in the Nebius AI Discovery Awards 2026
SOUTH SAN FRANCISCO, CA, Jun 12, 2026 – Synlico Inc., a Patient-Native Causal AI biotech, today announced it has been […]
News
News
Synlico’s Article “Causal Graphs: A Blueprint Driving Drug Discovery from Single-Cell Omics” Featured in Life Sciences Insights
South San Francisco, California, August 20, 2025 – Synlico Inc., is proud to announce that its article, “Causal Graphs: A
News
Synlico Selected Finalist in Johnson & Johnson Innovation QuickFire Challenge: Pitching AI for Pharmaceutical R&D
South San Francisco, California, October 4th, 2024 – Synlico Inc., an AI-based drug design company focusing on revolutionizing medicine by